LATOYA STEWART: Open Payments
NPI 1871145375 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,057 in 54 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $259 · 2025 $1,057
Food & beverage: $1,057
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $255 |
| Medtronic, Inc. | 4 | $162 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $118 |
| PFIZER INC. | 5 | $90 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| SCPHARMACEUTICALS INC. | 4 | $60 |
| Novo Nordisk Inc | 3 | $58 |
| Amgen Inc. | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
Products named: LEQVIO, JARDIANCE, AURORA EV-ICD MRI SURESCAN, Kerendia, ELIQUIS, CAMZYOS, FUROSCIX, Wegovy.
Industry payments across MD — which companies pay providers there.
